CAJ | 학술논문

目的：探讨超声评分系统结合血清附睾分泌蛋白4（human epididymal secretory protein 4，HE4）、CA125检测结果，对卵巢肿瘤的诊断意义。方法选取卵巢癌78例（卵巢癌组），卵巢良性肿瘤102例（卵巢良性肿瘤组），检测两组血清HE4及CA125水平，以80例健康人为对照组，制作受试者工作特征（ ROC）曲线，以曲线下面积（ AUC）反映诊断的准确性。对两组患者进行超声评分，分别计算超声评分系统与肿瘤标志物联合对卵巢癌诊断的敏感性、特异性。结果卵巢癌组血清HE4及CA125水平明显高于卵巢良性肿瘤组和对照组，差异均有统计学意义（P＜0．05）；卵巢良性肿瘤组与对照组间比较， HE4差异无统计学意义（P＞0．05），CA125差异有统计学意义（P＜0．05）。 HE4诊断卵巢癌的敏感性、特异性分别为94．3％，96．1％；CA125诊断卵巢癌的敏感性、特异性分别为87．4％，94．2％。 HE4联合超声评分系统敏感度为为91．4％；CA125联合超声评分系统为85．7％；HE4、CA125、超声评分系统三项联合检测为96．1％。结论血清HE4、CA125联合超声评分系统诊断卵巢肿瘤的敏感性最高。
목적：탐토초성평분계통결합혈청부고분비단백4（human epididymal secretory protein 4，HE4）、CA125검측결과，대란소종류적진단의의。방법선취란소암78례（란소암조），란소량성종류102례（란소량성종류조），검측량조혈청HE4급CA125수평，이80례건강인위대조조，제작수시자공작특정（ ROC）곡선，이곡선하면적（ AUC）반영진단적준학성。대량조환자진행초성평분，분별계산초성평분계통여종류표지물연합대란소암진단적민감성、특이성。결과란소암조혈청HE4급CA125수평명현고우란소량성종류조화대조조，차이균유통계학의의（P＜0．05）；란소량성종류조여대조조간비교， HE4차이무통계학의의（P＞0．05），CA125차이유통계학의의（P＜0．05）。 HE4진단란소암적민감성、특이성분별위94．3％，96．1％；CA125진단란소암적민감성、특이성분별위87．4％，94．2％。 HE4연합초성평분계통민감도위위91．4％；CA125연합초성평분계통위85．7％；HE4、CA125、초성평분계통삼항연합검측위96．1％。결론혈청HE4、CA125연합초성평분계통진단란소종류적민감성최고。
Objective To study significance of combined with ultrasound score and serum HE4, CA125 in differentiating ma-lignant from benign ovarian tumor.Methods Senventy-eight cases of epithelial ovarian cancer ( ovarian cancer group) and 102 cases of benign ovarian tumor (benign ovarian tumor group) measured the serum level of CA125, results are expressed as median (M) said. In 80 cases of normal people as control ( control group) .By making the receiver operating characteristic ( ROC) curve, the area under the curve (AUC) to reflect the accuracy of diagnosis.At the same time, ultrasonic scoring system scores of the two groups of patients, ultrasound scoring system and different tumor markers combination were calculated on the sensitivity, specificity of diagnosis of ovarian cancer.Results The serum HE4 and CA125 in ovarian cancer is significantly higher than that in benign ovarian tumor group and nor-mal control group, compared the differences were statistically significant (P<0.05); Compard ovarian benign tumor group and the normal control group, HE4 showed no statistically significant difference (P>0.05), CA125 show a significant difference(P<0.05). The specificity and sensitivity of HE4 were 94.3%, 96.1%; The specificity and sensitivity of CA125 were 87.4%, 94.2%.HE4 CA125, ultrasonic scoring system of combined detection of three kinds of sensitivity of 96.1%.Conclusions HE4 and CA125 in combination with ultrasonic scoring system for differential diagnosis of the highest sensitivity.